• linkedin
  • Increase Font
  • Sharebar

    Surveillance rarely used in stage 1, 2 prostate Ca

    More than 90% undergo surgery or radiation

    While close to 90% of men diagnosed with prostate cancer between 1998 and 2012 had stage 1 and stage 2 disease, more than 90% underwent surgery or radiation to treat the cancer, according to a study presented at the Genitourinary Cancers Symposium in Orlando, FL.

    Researchers analyzed the National Cancer Database from 1998 to 2012. Treatment status information was available for 337,658 of the 1,803,596 men diagnosed with prostate cancer during those years.

    They found that nearly 4% were under active surveillance, which is deferred treatment until it’s absolutely necessary, and 4% received no treatment or surveillance. Among the patients with stage 1 disease, 7.5% were followed with active surveillance and 2.22% of those with stage 2 prostate cancer had surveillance.

    Commentary: Why is AS for prostate Ca not used more?

    Nearly 63% had surgery to treat the cancer and 35% received radiation.

    Academic research programs were more likely than other types of centers to have patients undergoing active surveillance, taking the approach with 5.7%, or 7,524 men, during the years of the study.

    The researchers’ aim, according to lead author Jeanny B. Aragon-Ching, MD, was to determine whether the advent of active surveillance screening recommendation guidelines in Canada and the U.S. have changed day-to-day practice patterns.

    “Active surveillance was one of the biggest themes in the recent ASCO GU program,” said Dr. Aragon-Ching, clinical program director of genitourinary cancers at the Inova Schar Cancer Institute and associate professor of medicine, Virginia Commonwealth University in Fairfax.

    Next: Stage 2 PCa in 56% of surgical patients

    Lisette Hilton
    Lisette Hilton is a writer in Boca Raton, Fla., who heads up her company, Words Come Alive.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available